АНТИМИКРОБНАЯ И РАНОЗАЖИВЛЯЮЩАЯ АКТИВНОСТЬ ХИТОЗАН-ИММОБИЛИЗОВАННОГО ФИЦИНА
https://doi.org/10.20914/2304-4691-2020-3-282-284
Об авторах
Д. Р. БайдамшинаРоссия
Е. Ю. Тризна
Россия
М. Г. Холявка
Россия
А. Р. Каюмов
Россия
Список литературы
1. Shah D., Mital K. The role of trypsin: chymotrypsin in tissue repair //Advances in therapy. 2018. Т. 35. -№. 1. -С. 31-42.
2. Chandanwale A. et al. A randomized, clinical trial to evaluate efficacy and tolerability of trypsin: chymotrypsin as compared to serratiopeptidase and trypsin: bromelain: rutoside in wound management //Advances in therapy. -2017. -Т. 34. -№. 1. - С. 180-198.
3. Kirker K.R., James G.A. In vitro studies evaluating the effects of biofilms on wound-healing cells: a review //Apmis. -2017. - Т. 125. -№.
4. Malone M. et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data //Journal of Wound Care. -2017. -Т. 26. -№. 1. -С. 20-25.
5. Percival S.L. et al. A review of the scientific evidence for biofilms in wounds //Wound repair and regeneration. -2012. -Т.
6. Roy S. et al. Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function //The Journal of pathology. -2014. -Т. 233. -№.
7. Minaev B.F. Electronic mechanisms of molecular oxygen activation //Russ. Chem. Rev. -2007. Т. 76. №. 11. С. 989-1011.
8. Wang J. et al. Functional and bioinformatics analysis of an exopolysaccharide-relatedgene (epsN) from Lactobacillus kefiranofaciensZW3 //Archives of microbiology. -2016. -Т. 198. -№. 7. -С. 611-618.
9. Klasen H.J. A review on the nonoperative removal of necrotic tissue from burn wounds //Burns. -2000. -Т. 26. -№. 3. - С. 207-222.
10. Baidamshina D.R. et al. Targeting microbial biofilms using Ficin, a nonspecific plant protease //Scientific reports. -2017.
Рецензия
Для цитирования:
Байдамшина Д.Р., Тризна Е.Ю., Холявка М.Г., Каюмов А.Р. АНТИМИКРОБНАЯ И РАНОЗАЖИВЛЯЮЩАЯ АКТИВНОСТЬ ХИТОЗАН-ИММОБИЛИЗОВАННОГО ФИЦИНА. Актуальная биотехнология. 2020;(3):282-284. https://doi.org/10.20914/2304-4691-2020-3-282-284